Clinical trials
Recruiting Phase 2/3 trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 4 |
| 2025 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese University of Hong Kong | 3 |
| Institute of Hematology & Blood Diseases Hospital, China | 3 |
| Bristol-Myers Squibb | 1 |
| CSL Behring | 1 |
| Hospital Authority, Hong Kong | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Mirati Therapeutics Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| The University of Hong Kong | 1 |
| Tuen Mun Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Burkitt Lymphoma | 2 |
| Atherosclerosis | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Coronary Artery Disease | 1 |
| Dermatitis, Atopic | 1 |
| Diabetes Mellitus | 1 |
| Fatigue Syndrome, Chronic | 1 |
| Kidney Failure, Chronic | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.